Health condition
Mitochondrial disease testing pathway UK
Getting tested for suspected mitochondrial disease in the UK follows a defined pathway - from first-line blood genomic tests to specialist centre assessment - but waits can be long and the route confusing.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
Which gene and test confirm it, who should be tested in the family, and which specialist to see.
-
First-line testing is now genomic: mitochondrial DNA sequencing plus nuclear gene panels, often from blood or urine samples
-
The NHS Genomic Medicine Service sets eligibility criteria (R-codes) that GPs and specialists use to order tests
-
Three NHS highly specialised centres - Newcastle, London and Oxford - anchor diagnosis and care
-
Muscle biopsy is no longer the starting point; it is reserved for unresolved cases
Understanding the condition
What it is and what happens next.
What causes it, how it is confirmed, and the testing and specialist routes available in the UK.
What it is and how it presents
A decade ago the road to a mitochondrial diagnosis ran through a muscle biopsy; today it usually starts with a blood or urine sample sent for mitochondrial genome sequencing and a nuclear panel, ordered under the NHS Genomic Medicine Service's criteria. The practical difficulty is upstream: getting a clinician to suspect the diagnosis, assemble the multi-organ picture and make the referral - steps where patients often stall for years.
Testing, surveillance and specialist care
A referral to one of the specialised mitochondrial centres brings the pieces together: targeted genomics, cardiac and endocrine screening and, where variants are found, heteroplasmy testing of relatives with genetic counselling on maternal inheritance. Privately, an initial specialist review can organise the same investigations and route NHS-eligible testing appropriately. NHS clinical genetics services carry some of the longest waits in the health service, often many months for a first appointment, whereas private genetic testing and a specialist review can typically be arranged within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a neurologist at a specialist mitochondrial centre. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any emergency symptoms.
Frequently asked
Common questions about Mitochondrial disease testing pathway UK.
Quick, plain-English answers to what people ask us most.
-
What is the mitochondrial disease testing pathway in the UK?
This is the structured route by which patients with suspected mitochondrial disease are assessed, typically starting with a specialist neurology or metabolic clinic referral, followed by blood and urine metabolic tests, imaging, muscle biopsy where needed, and genetic testing. In England, testing is coordinated through designated NHS Highly Specialised Services for mitochondrial disease.
-
Why is testing for mitochondrial disease so involved?
Mitochondrial disease can affect almost any organ system and is caused by a very wide range of possible genetic mutations, so a stepwise approach combining clinical assessment, biochemical tests and targeted or broad genetic panels is needed to reach an accurate diagnosis.
-
What symptoms might prompt this testing pathway?
Doctors consider mitochondrial testing when someone has unexplained combinations of symptoms such as muscle weakness, exercise intolerance, seizures, hearing loss, diabetes, heart problems or developmental delay, especially if multiple unrelated organ systems are affected.
-
Is mitochondrial disease hereditary?
Yes, mitochondrial disease is genetic, but inheritance can be complex since mutations may be in mitochondrial DNA, inherited only from the mother, or in nuclear DNA, inherited in standard dominant or recessive patterns. Genetic counselling is an important part of the pathway.
-
What tests are typically included in the pathway?
Common tests include blood lactate and creatine kinase, urine organic acids, MRI brain imaging, cardiac and eye assessments, and increasingly, next-generation genetic sequencing panels, sometimes alongside a muscle biopsy for specialised staining and enzyme studies.
-
Can mitochondrial disease be cured?
There is currently no cure for most mitochondrial diseases, but many symptoms can be managed effectively, and specific vitamin or cofactor supplementation helps in certain subtypes. Ongoing research is developing targeted therapies for some specific genetic forms.
-
How long does the testing pathway usually take?
A full diagnostic work-up can take several months, particularly if genetic testing or muscle biopsy results are needed, though initial biochemical screening can sometimes give early clues within weeks. Coordination between multiple specialists can also add to the timeline.
-
When should I ask for referral onto the mitochondrial testing pathway, and how quickly can I be seen privately?
Ask for referral if you or your child has unexplained symptoms affecting multiple organ systems, particularly with a family history of similar problems. NHS specialist mitochondrial clinics have limited capacity and can involve long waits, whereas a private neurologist can typically arrange an initial assessment and start the work-up within about two weeks.